Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic.

Drug safety

Chandler RE, McCarthy D, Delumeau JC, Harrison-Woolrych M.
PMID: 32383008
Drug Saf. 2020 Jun;43(6):511-512. doi: 10.1007/s40264-020-00941-4.

No abstract available.

Cite
Chandler RE, McCarthy D, Delumeau JC, et al. The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic. Drug Saf. 2020;43(6):511-512doi: 10.1007/s40264-020-00941-4.
Chandler, R. E., McCarthy, D., Delumeau, J. C., & Harrison-Woolrych, M. (2020). The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic. Drug safety, 43(6), 511-512. https://doi.org/10.1007/s40264-020-00941-4
Chandler, Rebecca E, et al. "The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic." Drug safety vol. 43,6 (2020): 511-512. doi: https://doi.org/10.1007/s40264-020-00941-4
Chandler RE, McCarthy D, Delumeau JC, Harrison-Woolrych M. The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic. Drug Saf. 2020 Jun;43(6):511-512. doi: 10.1007/s40264-020-00941-4. PMID: 32383008; PMCID: PMC7203700.
Copy Download .nbib Format: NLM
Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need.

Science China. Life sciences

Zhang T, He Y, Xu W, Ma A, Yang Y, Xu KF.
PMID: 32124179
Sci China Life Sci. 2020 May;63(5):774-776. doi: 10.1007/s11427-020-1660-2. Epub 2020 Feb 29.

No abstract available.

Cite
Zhang T, He Y, Xu W, et al. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Sci China Life Sci. 2020;63(5):774-776doi: 10.1007/s11427-020-1660-2.
Zhang, T., He, Y., Xu, W., Ma, A., Yang, Y., & Xu, K. F. (2020). Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Science China. Life sciences, 63(5), 774-776. https://doi.org/10.1007/s11427-020-1660-2
Zhang, Tengyue, et al. "Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need." Science China. Life sciences vol. 63,5 (2020): 774-776. doi: https://doi.org/10.1007/s11427-020-1660-2
Zhang T, He Y, Xu W, Ma A, Yang Y, Xu KF. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Sci China Life Sci. 2020 May;63(5):774-776. doi: 10.1007/s11427-020-1660-2. Epub 2020 Feb 29. PMID: 32124179; PMCID: PMC7089458.
Copy Download .nbib Format: NLM
Therapeutic Cannabis and COVID-19: between opportunism and infoxication.

Adicciones

Pascual Pastor F, Isorna Folgar M, Carvalho N, Carvalho F, Arias Horcajadas F.
PMID: 32717094
Adicciones. 2020 Jul 01;32(3):167-172. doi: 10.20882/adicciones.1603.

Editorial.

Cite
Pascual Pastor F, Isorna Folgar M, Carvalho N, et al. Cannabis terapéutico y COVID-19: entre el oportunismo y la infoxicación. Therapeutic Cannabis and COVID-19: between opportunism and infoxication. Adicciones. 2020;32(3):167-172doi: 10.20882/adicciones.1603.
Pascual Pastor, F., Isorna Folgar, M., Carvalho, N., Carvalho, F., & Arias Horcajadas, F. (2020). Cannabis terapéutico y COVID-19: entre el oportunismo y la infoxicación. Therapeutic Cannabis and COVID-19: between opportunism and infoxication. Adicciones, 32(3), 167-172. https://doi.org/10.20882/adicciones.1603
Pascual Pastor, Francisco, et al. "Cannabis terapéutico y COVID-19: entre el oportunismo y la infoxicación." Therapeutic Cannabis and COVID-19: between opportunism and infoxication. Adicciones vol. 32,3 (2020): 167-172. doi: https://doi.org/10.20882/adicciones.1603
Pascual Pastor F, Isorna Folgar M, Carvalho N, Carvalho F, Arias Horcajadas F. Cannabis terapéutico y COVID-19: entre el oportunismo y la infoxicación. Therapeutic Cannabis and COVID-19: between opportunism and infoxication. Adicciones. 2020 Jul 01;32(3):167-172. doi: 10.20882/adicciones.1603. Spanish. PMID: 32717094.
Copy Download .nbib Format: NLM
Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database.

International journal of environmental research and public health

Lee SG, Park GU, Moon YR, Sung K.
PMID: 33218161
Int J Environ Res Public Health. 2020 Nov 18;17(22). doi: 10.3390/ijerph17228559.

BACKGROUND: We aimed to investigate the clinical characteristics and risk factors for fatality and severity in these patients.METHODS: In this nationwide population-based retrospective study, we investigated the data of 7339 laboratory-confirmed COVID-19 patients, aged ≥ 18 years, using the...

Cite
Lee SG, Park GU, Moon YR, et al. Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database. Int J Environ Res Public Health. 2020;17(22)doi: 10.3390/ijerph17228559.
Lee, S. G., Park, G. U., Moon, Y. R., & Sung, K. (2020). Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database. International journal of environmental research and public health, 17(22), . https://doi.org/10.3390/ijerph17228559
Lee, Seung-Geun, et al. "Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database." International journal of environmental research and public health vol. 17,22 (2020). doi: https://doi.org/10.3390/ijerph17228559
Lee SG, Park GU, Moon YR, Sung K. Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database. Int J Environ Res Public Health. 2020 Nov 18;17(22). doi: 10.3390/ijerph17228559. PMID: 33218161; PMCID: PMC7698934.
Copy Download .nbib Format: NLM
COVID-19 associated complications and potential therapeutic targets.

European journal of pharmacology

Monpara JD, Sodha SJ, Gupta PK.
PMID: 32926918
Eur J Pharmacol. 2020 Nov 05;886:173548. doi: 10.1016/j.ejphar.2020.173548. Epub 2020 Sep 12.

The global pandemic COVID-19, caused by novel coronavirus SARS-CoV-2, has emerged as severe public health issue crippling world health care systems. Substantial knowledge has been generated about the pathophysiology of the disease and possible treatment modalities in a relatively...

Cite
Monpara JD, Sodha SJ, Gupta PK. COVID-19 associated complications and potential therapeutic targets. Eur J Pharmacol. 2020;886:173548doi: 10.1016/j.ejphar.2020.173548.
Monpara, J. D., Sodha, S. J., & Gupta, P. K. (2020). COVID-19 associated complications and potential therapeutic targets. European journal of pharmacology, 886173548. https://doi.org/10.1016/j.ejphar.2020.173548
Monpara, Jasmin D, et al. "COVID-19 associated complications and potential therapeutic targets." European journal of pharmacology vol. 886 (2020): 173548. doi: https://doi.org/10.1016/j.ejphar.2020.173548
Monpara JD, Sodha SJ, Gupta PK. COVID-19 associated complications and potential therapeutic targets. Eur J Pharmacol. 2020 Nov 05;886:173548. doi: 10.1016/j.ejphar.2020.173548. Epub 2020 Sep 12. PMID: 32926918; PMCID: PMC7486300.
Copy Download .nbib Format: NLM
Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.

Advances in experimental medicine and biology

İnandıklıoğlu N, Akkoc T.
PMID: 32514817
Adv Exp Med Biol. 2020;1288:5-12. doi: 10.1007/5584_2020_549.

The world has given an outbreak alarm in the last two decades, with different members of the coronavirus family infecting people at different times. The spread of the SARS-CoV-2 virus, which last appeared in December 2019 in China and...

Cite
İnandıklıoğlu N, Akkoc T. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2. Adv Exp Med Biol. 2020;1288:5-12doi: 10.1007/5584_2020_549.
İnandıklıoğlu, N., & Akkoc, T. (2020). Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2. Advances in experimental medicine and biology, 12885-12. https://doi.org/10.1007/5584_2020_549
İnandıklıoğlu, Nihal, and Akkoc, Tunc. "Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2." Advances in experimental medicine and biology vol. 1288 (2020): 5-12. doi: https://doi.org/10.1007/5584_2020_549
İnandıklıoğlu N, Akkoc T. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2. Adv Exp Med Biol. 2020;1288:5-12. doi: 10.1007/5584_2020_549. PMID: 32514817.
Copy Download .nbib Format: NLM
A comparative overview of COVID-19, MERS and SARS: Review article.

International journal of surgery (London, England)

Liu J, Xie W, Wang Y, Xiong Y, Chen S, Han J, Wu Q.
PMID: 32730205
Int J Surg. 2020 Sep;81:1-8. doi: 10.1016/j.ijsu.2020.07.032. Epub 2020 Jul 26.

Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), a third, highly pathogenic coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appearing at end of 2019 led to a pandemic, increased...

Cite
Liu J, Xie W, Wang Y, et al. A comparative overview of COVID-19, MERS and SARS: Review article. Int J Surg. 2020;81:1-8doi: 10.1016/j.ijsu.2020.07.032.
Liu, J., Xie, W., Wang, Y., Xiong, Y., Chen, S., Han, J., & Wu, Q. (2020). A comparative overview of COVID-19, MERS and SARS: Review article. International journal of surgery (London, England), 811-8. https://doi.org/10.1016/j.ijsu.2020.07.032
Liu, Jie, et al. "A comparative overview of COVID-19, MERS and SARS: Review article." International journal of surgery (London, England) vol. 81 (2020): 1-8. doi: https://doi.org/10.1016/j.ijsu.2020.07.032
Liu J, Xie W, Wang Y, Xiong Y, Chen S, Han J, Wu Q. A comparative overview of COVID-19, MERS and SARS: Review article. Int J Surg. 2020 Sep;81:1-8. doi: 10.1016/j.ijsu.2020.07.032. Epub 2020 Jul 26. PMID: 32730205; PMCID: PMC7382925.
Copy Download .nbib Format: NLM
Pharmacologic Therapy for COVID-19 Infection.

Journal of community health

Nusbaum N.
PMID: 32314081
J Community Health. 2020 Jun;45(3):435-436. doi: 10.1007/s10900-020-00821-z.

The COVID-19 pandemic has focused attention on issues of epidemiology, public health, and vaccine design. I submit that attention to COVID-19 pharmacologic therapy needs similar emphasis, including identifying any existing medications that can be repurposed to treat COVID-19 patients.

Cite
Nusbaum N. Pharmacologic Therapy for COVID-19 Infection. J Community Health. 2020;45(3):435-436doi: 10.1007/s10900-020-00821-z.
Nusbaum, N. (2020). Pharmacologic Therapy for COVID-19 Infection. Journal of community health, 45(3), 435-436. https://doi.org/10.1007/s10900-020-00821-z
Nusbaum, Neil. "Pharmacologic Therapy for COVID-19 Infection." Journal of community health vol. 45,3 (2020): 435-436. doi: https://doi.org/10.1007/s10900-020-00821-z
Nusbaum N. Pharmacologic Therapy for COVID-19 Infection. J Community Health. 2020 Jun;45(3):435-436. doi: 10.1007/s10900-020-00821-z. PMID: 32314081; PMCID: PMC7169637.
Copy Download .nbib Format: NLM
COVID-19 and the Drug Repurposing Tsunami.

Assay and drug development technologies

Mucke HAM.
PMID: 32551883
Assay Drug Dev Technol. 2020 Jul;18(5):211-214. doi: 10.1089/adt.2020.996. Epub 2020 Jun 18.

No abstract available.

Cite
Mucke HAM. COVID-19 and the Drug Repurposing Tsunami. Assay Drug Dev Technol. 2020;18(5):211-214doi: 10.1089/adt.2020.996.
Mucke, H. A. M. (2020). COVID-19 and the Drug Repurposing Tsunami. Assay and drug development technologies, 18(5), 211-214. https://doi.org/10.1089/adt.2020.996
Mucke, Hermann A M. "COVID-19 and the Drug Repurposing Tsunami." Assay and drug development technologies vol. 18,5 (2020): 211-214. doi: https://doi.org/10.1089/adt.2020.996
Mucke HAM. COVID-19 and the Drug Repurposing Tsunami. Assay Drug Dev Technol. 2020 Jul;18(5):211-214. doi: 10.1089/adt.2020.996. Epub 2020 Jun 18. PMID: 32551883.
Copy Download .nbib Format: NLM
[No title available]

Revue medicale suisse

Nau JY.
PMID: 32270943
Rev Med Suisse. 2020 Apr 08;16(689):706-707.

No abstract available.

Cite
Nau JY. Miscellanées coronavirales, politiques et médicamenteuses. . Rev Med Suisse. 2020;16(689):706-707
Nau, J. Y. (2020). Miscellanées coronavirales, politiques et médicamenteuses. . Revue medicale suisse, 16(689), 706-707.
Nau, Jean-Yves. "Miscellanées coronavirales, politiques et médicamenteuses." . Revue medicale suisse vol. 16,689 (2020): 706-707.
Nau JY. Miscellanées coronavirales, politiques et médicamenteuses. . Rev Med Suisse. 2020 Apr 08;16(689):706-707. French. PMID: 32270943.
Copy Download .nbib Format: NLM
Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.

Journal of medical Internet research

Quirch M, Lee J, Rehman S.
PMID: 32707537
J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193.

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has challenged medicine and health care on a global scale. Its impact and frightening mortality rate are in large part attributable to the fact that there is a lack of available...

Cite
Quirch M, Lee J, Rehman S. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. J Med Internet Res. 2020;22(8):e20193doi: 10.2196/20193.
Quirch, M., Lee, J., & Rehman, S. (2020). Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. Journal of medical Internet research, 22(8), e20193. https://doi.org/10.2196/20193
Quirch, Miguel, et al. "Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review." Journal of medical Internet research vol. 22,8 (2020): e20193. doi: https://doi.org/10.2196/20193
Quirch M, Lee J, Rehman S. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193. PMID: 32707537; PMCID: PMC7428145.
Copy Download .nbib Format: NLM
COVID-19 and immunomodulation treatment for women with reproductive failures.

Journal of reproductive immunology

Kwak-Kim J, Ota K, Sung N, Huang C, Alsubki L, Lee S, Han JW, Han A, Yang X, Saab W, Derbala Y, Wang WJ, He Q, Liao A, Takahashi T, Cavalcante MB, Barini R, Bao S, Fukui A, Lédée N, Coulam C.
PMID: 32603991
J Reprod Immunol. 2020 Sep;141:103168. doi: 10.1016/j.jri.2020.103168. Epub 2020 Jun 12.

COVID-19 pandemic is affecting various areas of health care, including human reproduction. Many women with reproductive failures, during the peri-implantation period and pregnancy, are on the immunotherapy using immune modulators and immunosuppressant due to underlying autoimmune diseases, cellular immune...

Cite
Kwak-Kim J, Ota K, Sung N, et al. COVID-19 and immunomodulation treatment for women with reproductive failures. J Reprod Immunol. 2020;141:103168doi: 10.1016/j.jri.2020.103168.
Kwak-Kim, J., Ota, K., Sung, N., Huang, C., Alsubki, L., Lee, S., Han, J. W., Han, A., Yang, X., Saab, W., Derbala, Y., Wang, W. J., He, Q., Liao, A., Takahashi, T., Cavalcante, M. B., Barini, R., Bao, S., Fukui, A., Lédée, N., & Coulam, C. (2020). COVID-19 and immunomodulation treatment for women with reproductive failures. Journal of reproductive immunology, 141103168. https://doi.org/10.1016/j.jri.2020.103168
Kwak-Kim, Joanne, et al. "COVID-19 and immunomodulation treatment for women with reproductive failures." Journal of reproductive immunology vol. 141 (2020): 103168. doi: https://doi.org/10.1016/j.jri.2020.103168
Kwak-Kim J, Ota K, Sung N, Huang C, Alsubki L, Lee S, Han JW, Han A, Yang X, Saab W, Derbala Y, Wang WJ, He Q, Liao A, Takahashi T, Cavalcante MB, Barini R, Bao S, Fukui A, Lédée N, Coulam C. COVID-19 and immunomodulation treatment for women with reproductive failures. J Reprod Immunol. 2020 Sep;141:103168. doi: 10.1016/j.jri.2020.103168. Epub 2020 Jun 12. PMID: 32603991; PMCID: PMC7291967.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries